National Institute for Pharmaceutical Research and Development

Last updated

National Institute for Pharmaceutical Research and Development
AbbreviationNIPRD
Founded1987 (1987)
Headquarters Abuja, FCT, Nigeria
Coordinates 9°02′51″N7°20′29″E / 9.0475°N 7.3415°E / 9.0475; 7.3415
Official language
English
Director General
Obi Peter Adigwe
Parent organization
Federal Ministry of Health
Website https://www.niprd.gov.ng

The National Institute for Pharmaceutical Research and Development (NIPRD) is a Nigerian institution charged with developing drugs, biological products, and pharmaceutical raw materials, conducting quality-assurance tests, research for locally manufactured medicines and constituting guidelines for their production. [1] [2] Founded in 1987, it was a parastatal under the Federal Ministry of Science and Technology. In 2001, it was moved to Federal Ministry of Health. [3] [1]

Contents

History

Major drug developments

Niprisan

The NIPRD produces Niprisan for the management of sickle cell disorders. It is commercialized as Niclovix. [9] Niprisan is a phytochemical formulated from parts of four different indigenous plants ( Piper guineense seeds, Pterocarpusosun stem, Eugenia caryophyllus fruit and Sorghum bicolor leaves). In June 2018, May & Baker signed a production agreement with NIPRD for the commercialization of Niprisan in Nigeria. [10]

In July 2022, The Director-General of NIPRD, Dr. Obi Peter Adigwe, announced that more than 40 countries buy Niprisan from Nigeria. [11] [12]

Niprimune

In March 2020, under the directive of the Federal Government, the NIPRD started developing models to identify herbal medicines to combat COVID-19. [13] By early 2021, NIPRD had discovered Niprimune, a locally made phytomedicine as an adjunct for the management of COVID-19 [14] and was approved by the National Agency for Food and Drug Administration and Control (NAFDAC). [15] The Institute had decried lack of funding to advance its production and further research. [16] [17]

Controversies

See also

Related Research Articles

<span class="mw-page-title-main">University of Nigeria</span> Public university in Nsukka, Nigeria

The University of Nigeria, commonly referred to as UNN, is a federal university located in Nsukka, Enugu State, Eastern part of Nigeria. Founded by Nnamdi Azikiwe in 1955 and formally opened on 7 October 1960, the University of Nigeria has three campuses in Enugu State–Nsukka, Enugu, and Ituku-Ozalla – and the Aba campus in Abia State.

<span class="mw-page-title-main">European Medicines Agency</span> Agency of the European Union

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA).

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">2Baba</span> Nigerian musician (born 1975)

Innocent Ujah Idibia MON, known by his stage name 2Baba, is a Nigerian singer, songwriter, record producer, entrepreneur and philanthropist. Noted for his vocal range, lyrical depth, and longevity, he is widely regarded as one of Africa's greatest musicians of all time. He is most influential for the rise in popularity of Nigerian pop music in the 2000s, and his solo debut album Face2Face ushered in a new wave of awareness and reverence for Nigerian music amongst Africans on the continent and in diaspora. Prior to July 2014, he went by the stage name 2face Idibia. 2Baba is the first winner of MTV EMA Best African Act category in 2005, and is one of the most awarded Nigerian musicians in history.

<span class="mw-page-title-main">University of Jos</span> Public university in Jos, Nigeria

The University of Jos, abbreviated as Unijos, is a Federal University in Jos, Plateau State, central Nigeria.

<span class="mw-page-title-main">National Agency for Food and Drug Administration and Control</span> Government agency in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian federal agency under the Federal Ministry of Health that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, chemicals, and packaged water.

Nicosan, also known as Hemoxin, Niprisan, or Nix-0699, is a phytochemical which was studied in sickle-cell disease (SCD). As of 2017 it does not appear to be commercially available, as the only manufacturer, which was in Nigeria, has stopped producing it due to financial problems.

<span class="mw-page-title-main">Dora Akunyili</span> Nigerian pharmacist and government official (1954–2014)

Dora Nkem Akunyili was the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) of Nigeria from 2001 to 2008.

mPedigree refers both to a mobile telephony shortcode platform that interconnects GSM mobile networks in a number of African and Asian countries to a central registry wherein pedigree information of product brands belonging to participant manufacturers are stored, as well as the organisation that was founded in 2007 to manage and promote this registry to organisations and governments in Africa and other parts of the world. The latter is named the mPedigree Network. In December 2015, the mPedigree Network rebranded to 'mPedigree', and begun to trade under that name and a new logo, based on a knight-of-chess motif.

A counterfeit medication or a counterfeit drug is a medication or pharmaceutical item which is produced and sold with the intent to deceptively represent its origin, authenticity, or effectiveness. A counterfeit drug may contain inappropriate quantities of active ingredients, or none, may be improperly processed within the body, may contain ingredients that are not on the label, or may be supplied with inaccurate or fake packaging and labeling. Counterfeit drugs are related to pharma fraud. Drug manufacturers and distributors are increasingly investing in countermeasures, such as traceability and authentication technologies, to try to minimise the impact of counterfeit drugs. Antibiotics with insufficient quantities of an active ingredient add to the problem of antibiotic resistance.

<span class="mw-page-title-main">Agulu</span> Town in Anambra State, Nigeria

Agulu is a large town in Anambra State, Nigeria. It is located in Anaocha Local Government Area. Agulu is under the Anambra Central Senatorial District. It is home to the Agulu Lake. Agulu community has prominent men and women in politics, industries, academia and the government. The community also has produced a Governor in Anambra State in the person of Mr Peter Obi. Agulu is also known for the Agulu-Nanka erosion sites. Agulu comprises twenty villages. These are: Nwanchi, Nneohia, Okpu, Ama-Ezike, Odidama, Amorji, Isiamaigbo, Ukunu, Uhueme, Obeagu, Obe, Nkitaku, Okpu-Ifite, Umubialla, Amatutu, Umuowelle, Umunnowu, Ifiteani, Umuifite, and Nneogidi.

<span class="mw-page-title-main">Aspen Pharmacare</span> Major pharmaceutical company in South Africa

Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange (JSE) in 1998 and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals (ARVs) and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union.

<span class="mw-page-title-main">Chinedum Peace Babalola</span> First Nigerian Female Professor of Pharmacy

Chinedum Peace BabalolaFAS, FAAS is a Nigerian Professor of Pharmaceutical chemistry and Pharmacokinetics. She is the first female Professor of Pharmacy in the University of Ibadan, FAS and FAAS and the second female Nigerian FAAS. She is the incumbent Vice Chancellor of Chrisland University, Nigeria.

Mojisola Christianah Adeyeye is a Nigerian pharmacist and professor. She was appointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) on 3 November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari. Before her appointment as NAFDAC boss, she was the founding Chair of Biopharmaceutical Sciences and a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, where she spent 7 years. She was also a Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, Pennsylvania, USA. She is Senior Fulbright Scholar and Specialist and 2008 American Association of Pharmaceutical Scientists Fellow. She is also a Fellow of the Nigerian Academy of Science and Nigeria Academy of Pharmacy. Her research interests are in the areas of pre-formulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase drug product development. She is the founder and President of Elim Pediatric Pharmaceuticals Rolling Meadows, Illinois. Through Duquesne University, she was able to develop an anti-retroviral (HIV/AIDS) pediatric fixed-dose combination and received intellectual property on the formulations in the UK and South Africa.

NEIMETH International Pharmaceuticals PLC is a publicly listed pharmaceutical company founded in 1997 and headquartered in Lagos. It was established by a former managing director of Pfizer Products of Nigeria to acquire some of the trading assets of Pfizer International in Nigeria.

Traditional and Modern Health Practitioners Together against AIDS(THETA) is a non-government organization in Uganda that promotes collaboration between traditional healers and biomedical practitioners to prevent the spread of HIV/AIDS and provide care for HIV-positive patients. It was seen to be the first significant effort in Africa to involve traditional healers in the efforts against HIV/AIDS.

<span class="mw-page-title-main">CRISPR Therapeutics</span> Swiss-American biotechnology company

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award (FOYA) award in 2022. The company’s lead program, Exagamglogene autotemcel, or exa-cel, has been submitted for regulatory approval in 2023.

Patrick Engeu Ogwang is a Ugandan pharmacist, pharmacologist, ethnobotanist, medical researcher and entrepreneur, who serves as an associate professor and Head of the Department of Pharmacy at Mbarara University in Uganda. He concurrently serves as the Executive Chairman of Jena Herbals Uganda Limited, a private company that he founded that manufactures Covidex.

National Biotechnology Development Agency (NABDA) is an agency established in 2001 under the Federal Ministry of Science and Technology, that implements policies, explores resources, conducts research, promotes, coordinates and develops of biotechnology in Nigeria.

<span class="mw-page-title-main">Obi Peter Adigwe</span> Nigerian pharmacist

Obi Peter Adigwe is a Nigerian pharmacist and a doctor of pharmaceutical policy. He was appointed the Director General of the National Institute for Pharmaceutical Research and Development (NIPRD) with effect from 10 August 2018 by the former president of the Federal Republic of Nigeria, Muhammadu Buhari. Before his appointment as NIPRD boss, he was the Executive Secretary of the Pharmaceutical Manufacturers Group of the Manufacturers' Association of Nigeria and holds a Doctor of Pharmaceutical Policy at the University of Leeds, United Kingdom.

References

  1. 1 2 https://www.vanguardngr.com/2020/12/niprd-phytomedicine-verification-protocolll-improve-medicines-security-adigwe/
  2. David (2 August 2022). "Made-in-Nigeria medicines will diversify economy – DG NIPRD". The Sun Nigeria. Retrieved 16 February 2023.
  3. "NIPRD gets international accreditation for drug development". The Guardian Nigeria News - Nigeria and World News. 16 August 2018. Retrieved 15 February 2023.
  4. dib@usp.org (17 August 2018). "Nigeria's National Institute for Pharmaceutical Research and Development Attains International Accreditation". www.usp-pqm.org. Retrieved 15 February 2023.
  5. "Nigerian Institute Develops Drugs Ebola Malaria". www.premiumtimesng.com. Retrieved 15 February 2023.
  6. "Afreximbank Awards US$400,000 Grant to Nigeria's NIPRD to boost local Production of Active Pharmaceutical Ingredients". African Export-Import Bank. 8 November 2021. Retrieved 15 February 2023.
  7. Akor, Ojoma (11 April 2022). "NIPRD signs MoU with S/African varsity on traditional medicine". Daily Trust. Retrieved 15 February 2023.
  8. "Africa: Taking action to curb menace of transboundary diseases | The Nation Newspaper". The Nation Newspaper. 22 August 2022. Retrieved 15 February 2023.
  9. Akor, Ojoma (8 March 2022). "' How NIPRISAN is improving access to sickle cell treatment in Nigeria'". Daily Trust. Retrieved 15 February 2023.
  10. "Nigerian scientists patented a sickle cell drug using a herbal remedy—then it all fell apart". Quartz. 11 February 2019. Retrieved 16 February 2023.
  11. Racheal, Abujah (6 July 2022). "Sickle Cell Anaemia: Over 40 Nations Opt For Nigeria's Local Medicine – NIPRD Boss". Science Nigeria. Retrieved 15 February 2023.
  12. ADANIKIN, Olugbenga (26 August 2021). "Over 40 countries are demanding Nigeria's sickle cell drug - NIPRD DG". The ICIR- Latest News, Politics, Governance, Elections, Investigation, Factcheck, Covid-19. Retrieved 15 February 2023.
  13. "FG Directs Pharmaceutical Research Institute to Identify Herbal Medicines Active against COVID-19 – THISDAYLIVE". www.thisdaylive.com. Retrieved 15 February 2023.
  14. "Andrographis tops natural cures for COVID-19". The Guardian Nigeria News - Nigeria and World News. 29 April 2021. Retrieved 15 February 2023.
  15. https://www.vanguardngr.com/2021/01/covid-19-nafdac-approves-use-of-niprimune-as-immune-drug-says-niprd/
  16. https://www.vanguardngr.com/2021/01/covid-19-lack-of-sponsorship-hampering-niprds-efforts-in-vaccine-production-adigwe/
  17. "Crippled by poor funding, Nigerian drug research institute in darkness for nine months". www.premiumtimesng.com. Retrieved 16 February 2023.
  18. "Recruitment Scam: How Nigeria pharmaceutical institute employs through the back door". www.premiumtimesng.com. Retrieved 15 February 2023.
  19. "Why I don't advertise before recruitment – Nigeria Pharmaceutical Institute boss". www.premiumtimesng.com. Retrieved 15 February 2023.
  20. "Tension in Nigeria pharmaceutical institute over alleged diversion of World Bank grant, staff salaries". www.premiumtimesng.com. Retrieved 16 February 2023.